At the 2026 Oscars, comedian Conan O’Brien made a joke during a skit to open the show that negatively associated his appearance with make-up to having lupus. Using lupus as a punchline, especially ...

In light of litifilimab recently receiving FDA Breakthrough Therapy Designation for CLE, we spoke with experts to discuss diagnostic and treatment gaps in disease management.

Lupus is more common in Black people, and symptoms can be different too. Here's what to look out for and how to treat it.

Almost 90% of a cohort of patients with systemic lupus erythematosus reported experiencing depression or depressive symptoms ...

CEO Bob Valamehr outlined the company’s clinical and manufacturing strategy for FT819, an off-the-shelf allogeneic CAR T-cell therapy, during a conference fireside chat hosted by Leerink Partners ...

Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.

New analysis of Gazyva® shows the drug significantly reduces disease activity in adults with systemic lupus erythematosus.

Michael B. Jordan won his first Oscar at the 98th Academy Awards on Sunday, defeating movie stars Timothée Chalamet, Ethan ...

Johnson & Johnson's nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential ...

More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms after a year on the drug, researchers reported March 6 in The New England ...

The FDA grants Fast Track designation to nipocalimab for systemic lupus erythematosus following positive results from the phase 2b JASMINE trial.

One look at Chaos the husky and his blue eyes may have you thinking he's out of a fantasy novel or a wolf in a movie. However ...